Well Mr Incompetence, as you describe him, appears to be on a roll. In fact, Leronlimab appears to be on a roll and 13d is just going to be part of the past. Great response today re: taking the mask off 13d and their shenanigans. 13d have cost us a lot, in time, aggravation, obstructionism, and divisiveness. But it appears their days are numbered. I guess they won't be reimbursed for their expenses, so how much more are the remaining 13d ers going to toss into Rosenbaum's bottomless hat?
Emerging Growth should be interesting- hopefully get to audit it tonight.
CYTODYN LONG, STRONG, COMMITTED.
To 13d, you folks wanted IncellDX so badly, now you've got it ... enjoy the ride.
CYTODYN is running on a different track altogether and it looks like this baby is going to start gaining altitude...go Brazil, go NASH, go TNBC, go LH, go BLA for HIV, go Cancer(s), go Covid19
Yes GO LERONLIMAB!
IMO
News 
Market Data 
Discover 
